BANGALORE: Pharmaceutical and biotechnology major Wockhardt Ltd. has received USFDA approval for marketing Ketorolac, its anti-inflammatory injection in the U.S. market. This is its third FDA approval within ten days. Ketorolac is a potent non-steroidal anti-inflammatory drug used in the management of acute pain following surgery and trauma, says a release.